-
KU-60019: ATM Kinase Inhibitor Workflow
2026-09-16
Build reproducible glioma radiosensitization, DNA-repair, and migration assays with KU-60019, a selective ATM kinase inhibitor. This guide connects mechanism-driven controls with practical dosing, formulation, readout, and troubleshooting strategies for in vitro and exploratory in vivo research.
-
Deferiprone as a Tool for Iron-Stress Phenotyping
2026-09-15
Deferiprone enables controlled investigation of iron-stress phenotypes across metabolic, inflammatory, and tumor models. This article translates enterocyte metabolomics findings into a practical framework for choosing doses, controls, readouts, and cross-domain applications.
-
Hexetidine Mouthwash: A Systematic Review
2026-09-15
The reference study systematically evaluated hexetidine mouthwash for plaque control and gingival inflammation, narrowing 168 records to six eligible publications. Its descriptive comparison suggests that, despite antimicrobial activity, Hexetidine was not a convincing alternative to chlorhexidine when benefits and observed adverse effects were considered.
-
Fyn–Stat3 Signaling in Zebrafish Neurodegeneration
2026-09-14
This 2024 study identifies Stat3 as a downstream effector linking activated Fyn kinase to dopaminergic neuron loss and microglia activation in zebrafish. Its combination of cell-type-specific genetics, live imaging, transcriptomics, and pathway inhibition provides a useful framework for distinguishing Fyn-driven neurodegeneration from associated inflammatory responses.
-
Troglitazone PPARγ Agonist Workflows
2026-09-14
Troglitazone provides a practical PPARγ-centered perturbation tool for type 2 diabetes research, macrophage phenotyping, and exploratory renal carcinoma assays. This guide separates established receptor pharmacology from the emerging question of whether metabolic pathway modulation can influence SPP1-associated tumor myeloid states.
-
TH287 MTH1 Inhibitor: Reliable Cell Assays
2026-09-13
Learn how TH287 MTH1 inhibitor, SKU B5849, can support reproducible cell-viability, DNA-damage, and radiosensitization experiments. This scenario-based guide connects formulation, treatment timing, orthogonal readouts, and vendor-selection criteria to published CRPC findings and practical laboratory controls.
-
NU7441 and the DNA Damage–TDP-43 Axis
2026-09-12
A translational perspective on how NU7441 (KU-57788) can connect DNA-PK biology, DNA repair research, oncology research, and emerging questions about cytosolic DNA and TDP-43 homeostasis.
-
Lactobacillus reuteri 21 Protects Broiler Gut Health
2026-09-11
The reference study presents in ovo delivery of Lactobacillus reuteri 21 as a preventive strategy against Clostridium perfringens infection in Meiling yellow-feather broilers. Its main contribution is to connect early-life microbiota modulation with reuterin-associated immunomodulation and antioxidant defense, while also highlighting the limitations of inferring mechanism from integrated host–microbe measurements.
-
KG-501 in CREB–KIX Macrophage Assays
2026-09-11
KG-501 enables controlled interrogation of CREB–CBP and Myb–KIX transcriptional interfaces in macrophage, tumor, and reporter assays. This workflow-focused guide connects the compound to TLR4-driven colitis-associated colorectal cancer research while emphasizing dose validation, orthogonal readouts, and translational limitations.
-
Moesin as a Biomarker of Endothelial Injury in Sepsis
2026-09-10
The 2021 study identifies circulating moesin as a candidate indicator of sepsis-associated endothelial injury and links its abundance to clinical severity and pulmonary damage. By combining patient samples, mouse models, and HMEC experiments, the authors connect moesin to ROCK1/MLC and NF-κB signaling, while showing that moesin silencing reduces endothelial hyperpermeability and inflammatory activation.
-
Tubastatin A After Cardiac Arrest: Porcine Evidence
2026-09-10
A 2025 porcine study examined whether Tubastatin A could reduce myocardial injury after cardiac arrest and resuscitation. The treatment was associated with better cardiac function, lower injury biomarkers, and reduced signals of GSDME-linked pyroptosis, MLKL-linked necroptosis, and inflammation, although the mechanistic interpretation remains correlative.
-
Hesperadin: Aurora B Kinase Inhibitor Workflows
2026-09-09
Hesperadin offers a practical way to connect Aurora B activity with histone H3 phosphorylation, chromosome segregation, cytokinesis, and polyploidization. This workflow-focused guide explains dose design, checkpoint-oriented assays, reference-study integration, and troubleshooting for reproducible cell-cycle and cancer research.
-
Angiotensin 1/2 (1-6): A Translational RAS Lens
2026-09-09
A thought-leadership guide to using Angiotensin 1/2 (1-6) as a sequence-defined tool for renin-angiotensin system research, cardiovascular and renal experimentation, and carefully bounded exploration of angiotensin-linked viral biology.
-
PDK4-IN-1 hydrochloride: Applied Workflow Guide
2026-09-08
PDK4-IN-1 hydrochloride enables selective PDH activation for mechanistic studies of mitochondrial energy metabolism, glycolysis, and TCA-cycle flux. This practical guide connects concentration-response assays with orthogonal metabolic readouts and translational workflows for metabolic, cardiac, and tumor research.
-
AZD0156 for Reliable ATM Assays
2026-09-08
A scenario-based guide to using AZD0156 (SKU B7822) in cell viability, proliferation, and cytotoxicity workflows. It connects ATM biology, metabolic assay confounding, formulation, experimental controls, and vendor-selection criteria to improve interpretation and reproducibility.